Showing results (11-20 of 48) with videos related to
Sort By:
Pageof 5
Biological Research for Nursing|August 20, 2002
Issues in the design and implementation of psychoneuroimmunology researchF Patrick Robinson, Herbert L Mathews, Linda Witek-JanusekJournal of Alternative and Complementary Medicine (New York, N.Y.)|November 25, 2003
Psycho-endocrine-immune response to mindfulness-based stress reduction in individuals infected with the human immunodeficiency virus: a quasiexperimental studyF Patrick Robinson, Herbert L Mathews, Linda Witek-JanusekNephrology Nursing Journal : Journal of the American Nephrology Nurses' Association|April 5, 2003
HIV/AIDS and HIV nephropathyJerry Burns, Sharon Longton, F Patrick Robinson, et al.Nursing Forum|August 10, 2010
Perceptions of effective and ineffective nurse-physician communication in hospitalsF Patrick Robinson, Geraldine Gorman, Lynda W Slimmer, et al.International Journal of Nursing Education Scholarship|April 6, 2010
Online learning versus simulation for teaching principles of mechanical ventilation to nurse practitioner studentsSusan J Corbridge, F Patrick Robinson, Jennifer Tiffen, et al.Journal of Women'S Health (2002)|May 19, 2009
Self-reported medication and herb/supplement use by women with and without fibromyalgiaJoan L Shaver, JoEllen Wilbur, Hyeongkyeong Lee, et al.AIDS (London, England)|April 19, 2021
Applying a machine learning modelling framework to predict delayed linkage to care in patients newly diagnosed with HIV in Mecklenburg County, North Carolina, USAShi Chen, Yakubu Owolabi, Michael Dulin, et al.Nutritional Neuroscience|February 3, 2005
Caloric intake and hypothalamic neurotransmitters in Zucker rats made acutely diabetic with streptozocinFrank Svec, Patrick Robinson, Leslie Michel, et al.Current HIV Research|June 16, 2011
Effects of tipranavir, darunavir, and ritonavir on platelet function, coagulation, and fibrinolysis in healthy volunteersJens J Kort, Stella Aslanyan, Joseph Scherer, et al.Antimicrobial Agents and Chemotherapy|October 1, 2008
Pharmacokinetic and safety evaluation of BILR 355, a second-generation nonnucleoside reverse transcriptase inhibitor, in healthy volunteersFenglei Huang, Michael Koenen-Bergmann, Thomas R Macgregor, et al.Pageof 5